质母细胞瘤中的免疫检查点路径:一个多样化和不断变化的景观
Julio F Inocencio1, Stefan Mitrasinovic1, Mohammad Asad1
1Department of Neurological Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, United States.
Frontiers in immunology
|September 30, 2024
概括
免疫检查点 (IC) 抑制在质母细胞瘤 (GBM) 中表现出有限的成功,这是由于瘤的免疫抑制环境和冗余途径. 未来的研究必须探索针对IC和瘤微环境的组合疗法,以改善治疗耐药性.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 与其他癌症相比,免疫检查点 (IC) 抑制在质母细胞瘤 (GBM) 中产生了低于最佳的结果.
- GBM表现出一种深刻的免疫抑制瘤微环境 (TME).
- 冗余的信号通路和标准治疗对GBM的免疫性产生负面影响.
研究的目的:
- 在GBM中审查免疫检查点 (ICs).
- 检查IC和GBM TME之间的相互作用.
- 评估GBM中IC阻塞治疗的临床前和临床研究.
主要方法:
- 临床前和临床研究的文献综述.
- 在GBM中驱动IC的分子机制的分析.
- 评估当前治疗对GBM免疫环境的影响.
主要成果:
- GBM的免疫抑制TME和冗余IC通路阻碍了免疫治疗反应.
- 目前的标准治疗方法可能会对TME产生负面影响,影响IC阻塞的有效性.
- 了解ICs在GBM免疫抑制中的作用对于治疗进步至关重要.
结论:
- 为GBM开发有效的IC抑制疗法,需要深入了解其分子驱动因素和TME.
- 未来的战略应侧重于结合方法来克服治疗耐药性.
- 重新审视治疗方法及其免疫影响是设计新型GBM疗法的关键.
更多相关视频
09:17Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
Published on: September 13, 2022
2.3K
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
7.8K
相关概念视频
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
